DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
17	多系統萎縮症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03589976 (ClinicalTrials.gov)	September 1, 2018	5/7/2018	A Futility Trial of Sirolimus in Multiple System Atrophy	A Single Center Randomized,Double Blind, Placebo-controlled Futility Trial to Determine if Sirolimus is of Sufficient Promise to Slow the Progression of Multiple System Atrophy	Multiple System Atrophy	Drug: Sirolimus 2 MG;Other: Placebo	NYU Langone Health	National Institute of Neurological Disorders and Stroke (NINDS)	Recruiting	30 Years	80 Years	All	56	Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03589976
(ClinicalTrials.gov)

September 1, 2018

5/7/2018

A Futility Trial of Sirolimus in Multiple System Atrophy

A Single Center Randomized,Double Blind, Placebo-controlled Futility Trial to Determine if Sirolimus is of Sufficient Promise to Slow the Progression of Multiple System Atrophy

Multiple System Atrophy

Drug: Sirolimus 2 MG;Other: Placebo

NYU Langone Health

National Institute of Neurological Disorders and Stroke (NINDS)

Recruiting

30 Years

80 Years

All

Phase 2

United States